INSIGHT

Q3-2018 Home Health & Hospice Update

This September, The Centers for Medicare & Medicaid Services announced its latest proposed rule reducing administrative “red tape” and saving home health and hospice providers an estimated $137 million annually. Evident by the 35+ home health and hospice transactions being closed or announced in Q3, investors clearly remain bullish, which is translating into heightened valuation levels for groups of all sizes. With the increasingly prevalent threat of larger payors entering the space, like Humana, we continue to see smaller groups utilize M&A as a way to offset the burden of competing with data capabilities and scale. Moreover, platform capable groups are turning towards private equity to take advantage of acquisition opportunities through a roll-up strategy.

To print and download the full Home Health & Hospice Update report, please click below…


Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.
  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”